Reducing Transfusion-Related Acute Lung Injury Risk: Evidence for and Approaches to Transfusion-Related Acute Lung Injury Mitigation

Transfusion Medicine Reviews

Volumn 26, Issue 4, 2012, Pages 305-320

  Makar, Robert S ^a,b   Powers, Amy ^a,b   Stowell, Christopher P ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b QUEEN S MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FRESH FROZEN PLASMA; GRANULOCYTE ANTIBODY; HLA ANTIBODY; LEUKOCYTE ANTIBODY; PANEL REACTIVE ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ACUTE PANCREATITIS; ALLOIMMUNIZATION; ANTIBODY SPECIFICITY; ARTICLE; ATTRIBUTABLE RISK; BLOOD OXYGEN TENSION; BLOOD SAFETY; BLOOD TRANSFUSION REACTION; BLOOD VESSEL PERMEABILITY; BURN; CARDIOPULMONARY BYPASS; CRYOPRECIPITATE; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; INTENSIVE CARE UNIT; LUNG CONTUSION; LUNG EDEMA; MEDICAL RECORD REVIEW; MORBIDITY; MORTALITY; MULTIPLE TRAUMA; NULLIPARA; POSITIVE END EXPIRATORY PRESSURE; PREVALENCE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY FAILURE; RISK FACTOR; SCREENING; SEPSIS; SEX DIFFERENCE; THORAX RADIOGRAPHY; TRANSFUSION RELATED ACUTE LUNG INJURY; UNITED STATES;

ACUTE LUNG INJURY; ANIMALS; ANTIBODIES; BLOOD SAFETY; BLOOD TRANSFUSION; FEMALE; HUMANS; LEUKOCYTES; MALE; QUESTIONNAIRES; RABBITS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESPIRATORY DISTRESS SYNDROME, ADULT; RISK; RISK FACTORS;

EID: 84866449979     PISSN: 08877963     EISSN: 15329496     Source Type: Journal    
DOI: 10.1016/j.tmrv.2012.03.001     Document Type: Article

References (84)

1. Barnard R.D. Indiscriminate transfusion: a critique of case reports illustrating hypersensitivity reactions. N Y State J Med 1951, 51:2399-2402.
2. Brittingham T.E. Immunologic studies on leukocytes. Vox Sang 1957, 2:242-248.
3. Kernoff P.B., Durrant I.J., Rizza C.R., et al. Severe allergic pulmonary oedema after plasma transfusion. Br J Haematol 1972, 23:777-781.
4. Ward H.N. Pulmonary infiltrates associated with leukoagglutinin transfusion reactions. Ann Intern Med 1970, 73:689-694.
5. Ward H.N., Lipscomb T.S., Cawley L.P. Pulmonary hypersensitivity reaction after blood transfusion. Arch Intern Med 1968, 122:362-366.
6. Wolf C.F., Canale V.C. Fatal pulmonary hypersensitivity reaction to HL-A incompatible blood transfusion:report of a case and review of the literature. Transfusion 1976, 16:135-140.
7. Thompson J.S., Severson C.D., Parmely M.J., et al. Pulmonary "hypersensitivity" reactions induced by transfusion of non-HL-A leukoagglutinins. N Engl J Med 1971, 284:1120-1125.
8. Popovsky M.A., Abel M.D., Moore S.B. Transfusion-related acute lung injury associated with passive transfer of antileukocyte antibodies. Am Rev Respir Dis 1983, 128:185-189.
9. Popovsky M.A., Moore S.B. Diagnostic and pathogenetic considerations in transfusion-related acute lung injury. Transfusion 1985, 25:573-577.
10. Popovsky M.A., Chaplin H.C., Moore S.B. Transfusion-related acute lung injury: a neglected, serious complication of hemotherapy. Transfusion 1992, 32:589-592.
11. Seeger W., Schneider U., Kreusler B., et al. Reproduction of transfusion-related acute lung injury in an ex vivo lung model. Blood 1990, 76:1438-1444.
12. Sachs U.J., Hattar K., Weissmann N., et al. Antibody-induced neutrophil activation as a trigger for transfusion-related acute lung injury in an ex vivo rat lung model. Blood 2006, 107:1217-1219.
13. Looney M.R., Su X., Van Ziffle J.A., et al. Neutrophils and their Fc gamma receptors are essential in a mouse model of transfusion-related acute lung injury. J Clin Invest 2006, 116:1615-1623.
14. Looney M.R., Nguyen J.X., Hu Y., et al. Platelet depletion and aspirin treatment protect mice in a two-event model of transfusion-related acute lung injury. J Clin Invest 2009, 119:3450-3461.
15. Kelher M.R., Masuno T., Moore E.E., et al. Plasma from stored packed red blood cells and MHC class I antibodies causes acute lung injury in a 2-event in vivo rat model. Blood 2009, 113:2079-2087.
16. Sachs U.J., Wasel W., Bayat B., et al. Mechanism of transfusion-related acute lung injury induced by HLA class II antibodies. Blood 2011, 117:669-677.
17. Bux J., Sachs U.J. The pathogenesis of transfusion-related acute lung injury (TRALI). Br J Haematol 2007, 136:788-799.
18. Saidenberg E., Petraszko T., Semple E., et al. Transfusion-related acute lung injury (TRALI): a Canadian blood services research and development symposium. Transfus Med Rev 2010, 24:305-324.
19. Sachs U.J., Chavakis T., Fung L., et al. Human alloantibody anti-Mart interferes with Mac-1-dependent leukocyte adhesion. Blood 2004, 104:727-734.
20. Palfi M., Berg S., Ernerudh J., et al. A randomized controlled trial of transfusion-related acute lung injury: is plasma from multiparous blood donors dangerous?. Transfusion 2001, 41:317-322.
21. Mair D.C., Hirschler N., Eastlund T. Blood donor and component management strategies to prevent transfusion-related acute lung injury (TRALI). Crit Care Med 2006, 34:S137-S143.
22. Goldman M., Webert K.E., Arnold D.M., et al. Proceedings of a consensus conference: towards an understanding of TRALI. Transfus Med Rev 2005, 19:2-31.
23. Densmore T.L., Goodnough L.T., Ali S., et al. Prevalence of HLA sensitization in female apheresis donors. Transfusion 1999, 39:103-106.
24. Kopko P.M., Marshall C.S., MacKenzie M.R., et al. Transfusion-related acute lung injury: report of a clinical look-back investigation. JAMA 2002, 287:1968-1971.
25. Toy P., Hollis-Perry K.M., Jun J., et al. Recipients of blood from a donor with multiple HLA antibodies: a lookback study of transfusion-related acute lung injury. Transfusion 2004, 44:1683-1688.
26. Holness L., Knippen M.A., Simmons L., et al. Fatalities caused by TRALI. Transfus Med Rev 2004, 18:184-188.
27. Silliman C.C., Paterson A.J., Dickey W.O., et al. The association of biologically active lipids with the development of transfusion-related acute lung injury: a retrospective study. Transfusion 1997, 37:719-726.
28. Silliman C.C., Boshkov L.K., Mehdizadehkashi Z., et al. Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factors. Blood 2003, 101:454-462.
29. Silliman C.C., Ambruso D.R., Boshkov L.K. Transfusion-related acute lung injury. Blood 2005, 105:2266-2273.
30. Fatalities reported to FDA following blood collection and transfusion: annual summary for fiscal years 2005 and 2006 2006, CBER Office of Compliance and Biologics Quality, Rockville (Md).
31. Toy P., Popovsky M.A., Abraham E., et al. Transfusion-related acute lung injury: definition and review. Crit Care Med 2005, 33:721-726.
32. Bernard G.R., Artigas A., Brigham K.L., et al. Report of the American-European Consensus conference on acute respiratory distress syndrome: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Consensus Committee. J Crit Care 1994, 9:72-81.
33. Kleinman S., Caulfield T., Chan P., et al. Toward an understanding of transfusion-related acute lung injury: statement of a consensus panel. Transfusion 2004, 44:1774-1789.
34. Garber B.G., Hebert P.C., Yelle J.D., et al. Adult respiratory distress syndrome: a systemic overview of incidence and risk factors. Crit Care Med 1996, 24:687-695.
35. Koch C., Li L., Figueroa P., et al. Transfusion and pulmonary morbidity after cardiac surgery. Ann Thorac Surg 2009, 88:1410-1418.
36. Rana R., Fernandez-Perez E.R., Khan S.A., et al. Transfusion-related acute lung injury and pulmonary edema in critically ill patients: a retrospective study. Transfusion 2006, 46:1478-1483.
37. Toy P., Gajic O., Bacchetti P., et al. Transfusion related acute lung injury: incidence and risk factors. Blood 2012, 119:1757-1767.
38. Chapman C.E., Stainsby D., Jones H., et al. Ten years of hemovigilance reports of transfusion-related acute lung injury in the United Kingdom and the impact of preferential use of male donor plasma. Transfusion 2009, 49:440-452.
39. Keller-Stanislawski B., Reil A., Gunay S., et al. Frequency and severity of transfusion-related acute lung injury-German haemovigilance data (2006-2007). Vox Sang 2010, 98:70-77.
40. Ozier Y., Muller J.Y., Mertes P.M., et al. Transfusion-related acute lung injury: reports to the French Hemovigilance Network 2007 through 2008. Transfusion 2011, 51:2102-2110.
41. Eder A.F., Herron R.M., Strupp A., et al. Effective reduction of transfusion-related acute lung injury risk with male-predominant plasma strategy in the American Red Cross (2006-2008). Transfusion 2010, 50:1732-1742.
42. Eder A.F., Herron R., Strupp A., et al. Transfusion-related acute lung injury surveillance (2003-2005) and the potential impact of the selective use of plasma from male donors in the American Red Cross. Transfusion 2007, 47:599-607.
43. van Stein D., Beckers E.A., Sintnicolaas K., et al. Transfusion-related acute lung injury reports in the Netherlands: an observational study. Transfusion 2010, 50:213-220.
44. Tynell E., Andersson T.M., Norda R., et al. Should plasma from female donors be avoided? A population-based cohort study of plasma recipients in Sweden from 1990 through 2002. Transfusion 2010, 50:1249-1256.
45. Middelburg R.A., van Stein D., Briet E., et al. The role of donor antibodies in the pathogenesis of transfusion-related acute lung injury: a systematic review. Transfusion 2008, 48:2167-2176.
46. Gajic O., Rana R., Winters J.L., et al. Transfusion-related acute lung injury in the critically ill: prospective nested case-control study. Am J Respir Crit Care Med 2007, 176:886-891.
47. Vlaar A.P., Hofstra J.J., Determann R.M., et al. The incidence, risk factors, and outcome of transfusion-related acute lung injury in a cohort of cardiac surgery patients: a prospective nested case-control study. Blood 2011, 117:4218-4225.
48. Transfusion-related acute lung injury. Association Bulletin #06-07 2006, AABB, Bethesda (Md).
49. Kleinman S., Grossman B., Kopko P. A national survey of transfusion-related acute lung injury risk reduction policies for platelets and plasma in the United States. Transfusion 2010, 50:1312-1321.
50. Fatalities feported to FDA following blood collection and transfusion: annual summary for fiscal year 2008 2009, CBER Office of Compliance and Biologics Quality, Rockville (Md).
51. Wiersum-Osselton J.C., Middelburg R.A., Beckers E.A., et al. Male-only fresh-frozen plasma for transfusion-related acute lung injury prevention: before-and-after comparative cohort study. Transfusion 2011, 51:1278-1283.
52. Makar R.S., Saidman S.L., Stowell C.P., et al. Analysis of cutoffs for screening sensitized blood donors for HLA alloantibodies using a cytometric microbead assay. Transfusion 2011, 51:166-174.
53. Rios J.A., Schlumpf K.S., Kakaiya R.M., et al. Blood donations from previously transfused or pregnant donors: a multicenter study to determine the frequency of alloexposure. Transfusion 2011, 51:1197-1206.
54. Powers A., Stowell C.P., Dzik W.H., et al. Testing only donors with a prior history of pregnancy or transfusion is a logical and cost-effective transfusion-related acute lung injury prevention strategy. Transfusion 2008, 48:2549-2558.
55. Triulzi D.J., Kleinman S., Kakaiya R.M., et al. The effect of previous pregnancy and transfusion on HLA alloimmunization in blood donors: implications for a transfusion-related acute lung injury risk reduction strategy. Transfusion 2009, 49:1825-1835.
56. van de Watering L., Hermans J., Witvliet M., et al. HLA and RBC immunization after filtered and buffy coat-depleted blood transfusion in cardiac surgery: a randomized controlled trial. Transfusion 2003, 43:765-771.
57. Maslanka K., Michur H., Zupanska B., et al. Leucocyte antibodies in blood donors and a look back on recipients of their blood components. Vox Sang 2007, 92:247-249.
58. Reil A., Keller-Stanislawski B., Gunay S., et al. Specificities of leucocyte alloantibodies in transfusion-related acute lung injury and results of leucocyte antibody screening of blood donors. Vox Sang 2008, 95:313-317.
59. Middelburg R.A., Porcelijn L., Lardy N., et al. Prevalence of leucocyte antibodies in the Dutch donor population. Vox Sang 2011, 100:327-335.
60. Carrick D.M., Norris P.J., Endres R.O., et al. Establishing assay cutoffs for HLA antibody screening of apheresis donors. Transfusion 2011, 51:2092-2101.
61. Carrick D.M., Johnson B., Kleinman S.H., et al. Agreement among HLA antibody detection assays is higher in ever-pregnant donors and improved using a consensus cutoff. Transfusion 2011, 51:1105-1116.
62. Hashimoto S., Nakajima F., Kamada H., et al. Relationship of donor HLA antibody strength to the development of transfusion-related acute lung injury. Transfusion 2010, 50:2582-2591.
63. Nordhagen R., Conradi M., Dromtorp S.M. Pulmonary reaction associated with transfusion of plasma containing anti-5b. Vox Sang 1986, 51:102-107.
64. Chapman C.E., Williamson L.M., Cohen H., et al. The impact of using male donor plasma on haemovigilance reports of transfusion related acute lung injury (TRALI) in the UK. Vox Sang 2006, 91(Suppl. 3):227.
65. Bierling P., Bux J., Curtis B., et al. Recommendations of the ISBT Working Party on Granulocyte Immunobiology for leucocyte antibody screening in the investigation and prevention of antibody-mediated transfusion-related acute lung injury. Vox Sang 2009, 96:266-269.
66. Gottschall J.L., Triulzi D.J., Curtis B., et al. The frequency and specificity of human neutrophil antigen antibodies in a blood donor population. Transfusion 2011, 51:820-827.
67. Nguyen X.D., Flesch B., Sachs U.J., et al. Rapid screening of granulocyte antibodies with a novel assay: flow cytometric granulocyte immunofluorescence test. Transfusion 2009, 49:2700-2708.
68. Greinacher A., Wesche J., Hammer E., et al. Characterization of the human neutrophil alloantigen-3a. Nat Med 2010, 16:45-48.
69. Curtis B.R., Cox N.J., Sullivan M.J., et al. The neutrophil alloantigen HNA-3a (5b) is located on choline transporter-like protein 2 and appears to be encoded by an R > Q154 amino acid substitution. Blood 2010, 115:2073-2076.
70. Shanwell A., Kristiansson M., Remberger M., et al. Generation of cytokines in red cell concentrates during storage is prevented by prestorage white cell reduction. Transfusion 1997, 37:678-684.
71. Sparrow R.L., Patton K.A. Supernatant from stored red blood cell primes inflammatory cells: influence of prestorage white cell reduction. Transfusion 2004, 44:722-730.
72. Watkins T.R., Rubenfeld G.D., Martin T.R., et al. Effects of leukoreduced blood on acute lung injury after trauma: a randomized controlled trial. Crit Care Med 2008, 36:1493-1499.
73. Wendel S., Biagini S., Trigo F., et al. Measures to prevent TRALI. Vox Sang 2007, 92:258-277.
74. Kor D.J., Kashyap R., Weiskopf R.B., et al. Fresh red blood cell transfusion and short-term pulmonary, immunologic, and coagulation status: a randomized clinical trial. Am J Respir Crit Care Med 2012, Epub ahead of print.
75. Middelburg R.A., Borkent B., Jansen M., et al. Storage time of blood products and transfusion-related acute lung injury. Transfusion 2012, 52:658-667.
76. Baudoux E, Margraff U, Coenen A, et al. Hemovigilance: clinical tolerance of solvent-detergent treated plasma. Vox Sang 1998, 74(Suppl 1):237-239.
77. Flesland O A comparison of complication rates based on published haemovigilance data. Intensive Care Med 2007, 33(Suppl 1):S17-S21.
78. Sachs U.J., Kauschat D., Bein G. White blood cell-reactive antibodies are undetectable in solvent/detergent plasma. Transfusion 2005, 45:1628-1631.
79. Kleinman S.H., Triulzi D.J., Murphy E.L., et al. The Leukocyte Antibody Prevalence Study-II (LAPS-II): a retrospective cohort study of transfusion-related acute lung injury in recipients of high-plasma-volume human leukocyte antigen antibody-positive or -negative components. Transfusion 2011, 51:2078-2091.
80. Zhou L., Giacherio D., Cooling L., et al. Use of B-natriuretic peptide as a diagnostic marker in the differential diagnosis of transfusion-associated circulatory overload. Transfusion 2005, 45:1056-1063.
81. Tobian A.A., Sokoll L.J., Tisch D.J., et al. N-terminal pro-brain natriuretic peptide is a useful diagnostic marker for transfusion-associated circulatory overload. Transfusion 2008, 48:1143-1150.
82. Li G., Daniels C.E., Kojicic M., et al. The accuracy of natriuretic peptides (brain natriuretic peptide and N-terminal pro-brain natriuretic) in the differentiation between transfusion-related acute lung injury and transfusion-related circulatory overload in the critically ill. Transfusion 2009, 49:13-20.
83. Middelburg R.A., Van Stein D., Zupanska B., et al. Female donors and transfusion-related acute lung injury: a case-referent study from the International TRALI Unisex Research Group. Transfusion 2010, 50:2447-2454.
84. Middelburg R.A., van Stein D., Atsma F., et al. Alloexposed blood donors and transfusion-related acute lung injury: a case-referent study. Transfusion 2011, 51:2111-2117.